Patent · US Expired

Implant and agent delivery device

US6855160B1 · kind B1 · utility

15Cited by
150References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2000
Grant dateFeb 15, 2005
Priority date
Expiry dateMar 14, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2250/0067
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention provides a system for delivering a therapeutic agent in combination with an implanted device to maximize a therapeutic benefit offered by each. Preferably, the therapeutic agent is contained within a solid matrix form such as a pellet or gel to facilitate its handling, and to regulate its rate of dissipation into the tissue after delivery. The implant device is specially configured to receive retain the matrix but permit blood to interact with the matrix so that the agent can be released to the blood in, around the device, and the surrounding tissue. A delivery system comprises an implant delivery device having an obturator capable of piercing the tissue and an agent matrix delivery device to place a matrix form, such as a pellet, into the interior of the implant after it has been implanted. Preferably, the implant delivery device and the matrix delivery device are contained in one apparatus to facilitate delivery of the pellet into the embedded implant. The present invention is useful for treating tissue in any area of the body, especially ischemic tissue experiencing reduced blood flow. The present devices and methods are especially useful for treatment of i…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.